DrugDashboards

Fosaprepitant

Fosaprepitant · FOSAPREPITANT DIMEGLUMINE 150 mg/5mL · Injection, Powder, Lyophilized, For Solution · Intravenous · Dr. Reddy's Laboratories Inc.,

NDC 43598-0948-11 · 1 VIAL in 1 CARTON / 1 mL in 1 VIAL · ANDA · View full market →

The short version

10 companies supply this market — deep enough that no single failure threatens the supply. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$38.51per EAinvoice-surveyed acquisition cost · Aug 21, 2024
  • Medicare Part B pays (ASP+6%)$0.1230per billing unit (1 MG)HCPCS J1453 · Jul 1, 2026

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$20.00$40.00Aug 2024Aug 2024$38.51
2 price points · per EA · last surveyed Aug 21, 2024Source: CMS NADAC

Estimated fill cost

WAC per package, as filed
$82.18
Reported to Texas DSHS · 2026 annual filing · Dr. Reddy's Laboratories, Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 1 MG
$0.123
HCPCS J1453 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$179,791
5,102 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

10● Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • sterile injectable+10

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA209965
TE code
AP
Approval date
Sep 5, 2019
Patents / exclusivity
None on file

Shortage history

  • Planned discontinuation — Fosaprepitant Dimeglumine, Injection, 150 mg/5 mL (NDC 63323-972-10)Apr 8, 2026

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Fosaprepitant (Injection, Powder, Lyophilized, For Solution)

LabelerStrengthFirst seenLast seen
Novadoz Pharmaceuticals LLCFOSAPREPITANT DIMEGLUMINE 150 mg/5mLJul 15, 2026Sep 3, 2026
Actavis Pharma, Inc.FOSAPREPITANT DIMEGLUMINE 150 mg/1Jul 15, 2026Sep 2, 2026
BE Pharmaceuticals Inc.FOSAPREPITANT DIMEGLUMINE 150 mg/5mLJul 15, 2026Sep 2, 2026
BluePoint LaboratoriesFOSAPREPITANT DIMEGLUMINE 150 mg/5mLJul 15, 2026Sep 2, 2026
Bryant Ranch PrepackFOSAPREPITANT DIMEGLUMINE 150 mg/5mLJul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories Inc.,FOSAPREPITANT DIMEGLUMINE 150 mg/1Jul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCFOSAPREPITANT DIMEGLUMINE 150 mg/5mLJul 15, 2026Sep 2, 2026
Mylan Institutional LLCFOSAPREPITANT DIMEGLUMINE 150 mg/5mLJul 15, 2026Sep 2, 2026
Northstar Rx LLCFOSAPREPITANT DIMEGLUMINE 150 mg/5mLJul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories Inc.,FOSAPREPITANT DIMEGLUMINE 150 mg/5mLJul 15, 2026Aug 31, 2026
AVYXA Pharma, LLCFOSAPREPITANT DIMEGLUMINE 150 mg/5mLJul 31, 2026Aug 28, 2026
Avyxa Pharma, LLCFOSAPREPITANT DIMEGLUMINE 150 mg/5mLJul 15, 2026Jul 29, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Fosaprepitant — NDC 43598-0948-11," retrieved September 3, 2026, https://drugdashboards.com/drug/43598094811.

Free to cite with attribution — see how the data is put together.